IB

International Biotechnology Trust

Europe, England, United Kingdom, London

Description

International Biotechnology Trust offers investors access to the fast growing biotechnology sector through an actively managed fund.

Investor Profile

International Biotechnology Trust has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Series C (25%)
  • Series B (25%)
  • Series Unknown (25%)
  • Series A (13%)
  • Series D (13%)

Country Focus

  • United Kingdom (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical Device
  • Therapeutics
  • Life Science
  • Information Technology
  • Medical
  • Developer Platform
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does International Biotechnology Trust frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 6
3i Group
Europe, England, United Kingdom, London
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
Advent Venture Partners
Europe, England, United Kingdom, London
Co-Investments: 2
Red Abbey Venture Partners
North America, Maryland, United States, Baltimore
Co-Investments: 2
Imperial Innovations
Europe, England, United Kingdom, London
Co-Investments: 1
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by International Biotechnology Trust?

Autifony Therapeutics

London, England, United Kingdom

Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.

BiotechnologyMedical DeviceTherapeutics
Series AJul 10, 2015
Amount Raised: $12,413,763
Karus Therapeutics

Chilworth, Hampshire, United Kingdom

Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.

BiotechnologyLife SciencePharmaceutical
Series BSep 6, 2012
Amount Raised: $7,600,000
Oxagen

London, England, United Kingdom

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CNov 24, 2009
Amount Raised: $26,700,000
Sutro Biopharma

South San Francisco, California, United States

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

BiotechnologyInformation TechnologyMedical
Series UnknownOct 16, 2007
Amount Raised: $305,000
GlycoFi Inc.

Hanover, New Hampshire, United States

GlycoFi is a bio tech firm that develops bio-therapeutics based on the glycan optimization technology.

BiotechnologyHealth Care
Series COct 9, 2005
Amount Raised: $11,000,000
Oxagen

London, England, United Kingdom

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BMay 23, 2005
Amount Raised: $59,800,000
Aderis Pharmaceuticals

Richmond, Virginia, United States

Aderis Pharmaceuticals focused on discovery, development and commercialization of products for the diagnosis.

BiopharmaBiotechnologyDeveloper PlatformHealth Diagnostics
Series DOct 9, 2001
Amount Raised: $45,000,000
eBioinformatics

Pleasanton, California, United States

eBioinformatics provides bioinformatics services to the worldwide bioscience research efforts.

BioinformaticsBiotechnologyInformation Services
Series UnknownMay 30, 2000
Amount Raised: $10,000,000